✦ LIBER ✦

Defecatory function in Parkinson's disease: Response to apomorphine

✍ Scribed by L. L. Edwards; E. M. M. Quigley; R. K. Harned; Ruth Hofman; Dr. R. F. Pfeiffer

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 648 KB
Volume: 33
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410330512

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopaminergic responsiveness to apomorphi

Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease

✍ J. Vaamonde; M. R. Luquin; Dr. J. A. Obeso 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract The aim of this study was to assess whether or not continuous infusion of lisuride in combination with intermittent levodopa‐carbidopa administration was associated with tolerance. Intravenous apomorphine was given to four patients before initiation of chronic treatment with subcutaneou

Mitochondrial function in Parkinson's di

Mitochondrial function in Parkinson's disease

✍ Fiorenzo Dagani; Jeffrey J. Anderson; Thomas N. Chase 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 2 views

Mitochondrial function in Parkinson's di

Mitochondrial function in Parkinson's disease

✍ Prof. Anthony H. V. Schapira; Vincent M. Mann; J. Mark Cooper; David Krige; Pete 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 1000 KB

Functional COMT variant predicts respons

Functional COMT variant predicts response to high dose pyridoxine in Parkinson's disease

✍ Eng-King Tan; Sin-Yun Cheah; Stephanie Fook-Chong; Kenneth Yew; V.R. Chandran; S 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

Pyridoxal-5-phosphate, the biological active form of pyridoxine, is a cofactor for dopa-decarboxylase (DDC) enzyme. Pyridoxine may augment the conversion of levodopa to dopamine in the periphery and therefore decrease availability of levodopa to the brain. However, this effect can be negated in the

Function of dopamine receptors in young-

Function of dopamine receptors in young-onset parkinson's disease: Prolactin response

✍ Dr. Vladimir S. Kostic; Zorica Marinkovic; Sasa Filipovic; Dragana Momcilovic 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

## Abstract The basal levels of prolactin (PRL) and their changes after i. v. thyrotropin releasing hormone (TRH) administration after bromocriptine (BCT) pretreatment (BCT/TRH test) were monitored in 12 patients with young‐onset Parkinson's disease (PD) (before 40 years of age) and 10 patients wit

Retronasal olfactory function in Parkins

Retronasal olfactory function in Parkinson's disease

✍ Basile N. Landis; Hélène Cao Van; Nils Guinand; Judit Horvath; Antje Haehner; El 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract ## Objectives/Hypothesis: Orthonasal olfaction is severely altered in PD patients. Retronasal olfactory function has been shown to be preserved under certain conditions even in the absence of orthonasal function. This study was undertaken to investigate retronasal versus orthonasal olf